Publication Year: 2017
-
Development of ddPCR blood-based diagnostic tests that simultaneously measure mRNA expression from immune and cancer cells.
-
Utility of blood-based genomic and proteomic tests for non-small cell lung cancer
-
Integration of the Clin-ToF into the VeriStrat clinical testing workflow to generate serum protein profiles for prognosis and therapeutic guidance in NSCLC
-
Second‐line afatinib vs erlotinib for patients with squamous cell carcinoma (SCC) of the lung (LUXLung 8 [LL8]): analysis of tumour and serum biomarkers and long‐term responders